newsfilter
← Latest News
Business Wire·

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million

Tectonic will be focused on advancing a pipeline of novel G-protein-coupled receptor ("GPCR") targeted biologic therapies, including the lead program, TX45, a Fc-relaxin fusion TX45 is currently being evaluated in